3140 results for «238»
3140 results
Lean TAVI: safe efficiencies and better economics
21 Nov 2021 – From PCR London Valves 2021
Join Dider Tchétché and Stefan Toggweiler if you want to learn about the Lean TAVI practice and the Lucerne study results, the Lean TAVI adoption at other centres / Heart Teams, as well as the procedural efficiencies and their importance in the success of the overall...
TAVI in bicuspid aortic valves
21 Nov 2021 – From PCR London Valves 2021
Thanks to this series of videos from PCR London Valves 2021, analyze the results of self-expandable versus balloon-expandable transcatheter valves in bicuspid aortic anatomy, study the outcomes after TAVI in bicuspid aortic valve, and much more!
The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice
21 Nov 2021 – From PCR London Valves 2021
Join Raúl Moreno, Julian Widder and Mathias Wolfrum if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.
Is image fusion needed or too complex for standard transcatheter edge-to-edge repair?
21 Nov 2021 – From PCR London Valves 2021
Join Covadonga Fernandez-Golfin, Roberto Corti and Patric Biaggi if you want to learn about the benefits of image fusion and discover some tips and tricks on how to make image fusion easy and not complex in transcatheter edge-to-edge-repair.
TAVI procedure planning and optimising patient outcomes
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to evaluate whether TAVICT scans can replace invasive coronary angiography pre-TAVI, to appreciate how pre-operative computed tomography evaluation of aortic burden can predict acute kidney injury post-TAVR, and to appraise mortality in TAVI patients converted to...
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
Outcomes following transcatheter and percutaneous mitral valve repair
21 Nov 2021 – From PCR London Valves 2021
CLASP study, predictability of post-delivery residual mitral regurgitation, MiCLASP PMCF study, off-pump transapical neochord implantation, pronostic impact of nutritional status, and patients with low, intermediate and high frailty are the focus of this session from PCR LV 2021 devoted to percutaneous and transcatheter mitral valve repair.
Transcatheter mitral, aortic and pulmonary valve implantation
21 Nov 2021 – From PCR London Valves 2021
Watch this series of videos from PCR London Valves 2021 to learn about acute heart failure hospitalizations following TAVI in the U.S., share a peripheral hospital's experiences with structural valve service modernization, enjoy percutaneous transseptal mitral valve implantation in Brazil, and more!
Cases on miscellaneous coronary interventions
15 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover a selection of cases on miscellaneous coronary interventions unveiled at GulfPCR-GIM 2021: imaging-guided multivessel PCI in left main with TVD with rotablation in a ESRD, tiger catheter-induced left main occlusion, using IVL instead of rotational atherectomy, PCI of LIMA-LAD at anastomotic site in single surviving artery, aortocoronary dissection...
Cases on STEMI
15 Dec 2021 – From GulfPCR-GIM 2021
Watch this session to discover a selection of STEMI cases presented at GulfPCR-GIM 2021, and learn more about: the treatment of intramural haematoma and AMI, the role of plaque modifying device in ACS, the therapeutic strategy for a pan-coronary vulnerability, the importance of stent visualisation to improve...
Mitral valve disease: state-of-the-art
21 Nov 2021 – From PCR London Valves 2021
Did you ever wonder what an expert surgeon can achieve today in mitral repair? Have you ever wondered when to treat an asymptomatic patient with severe mitral regurgitation? These are some of the questions this session from PCR London Valves 2021 will try to answer.
Transcatheter mitral interventions: the future
21 Nov 2021 – From PCR London Valves 2021
What could be the future of transcatheter mitral valve intervention? Will it be repair or replacement? What are the current limitations? Find parts of the answers to these questions, and many others, in this session shot during the PCR LV 2021 Congress.
Mitral valve disease: guidelines and beyond
21 Nov 2021 – From PCR London Valves 2021
In this session from PCR London Valves 2021 dedicated to the new guidelines relating to the management of mitral valve disease, discover how to apply them in your everyday clinical practice to the care of your patients through presentations, interviews, heart team discussions, a live case...
Procedural aspects of TAVI patient long-term management
22 Nov 2021 – From PCR London Valves 2021
At the PCR London Valves 2021 Congress, a session was proposed to discuss long-term management of TAVI patients: gain knowledge in procedural PCI access after TAVI through case examples, and learn more about the essential steps of the cusp overlap implantation technique by watching it now!
Practical solutions to grow your TAVI programme - peer-to-peer case sharing
23 Nov 2021 – From PCR London Valves 2021
Thanks to this PCR London Valves 2021 session, explore real-world examples of how to use digital communication successfully with your referral network, discover practical ways to implement a TAVI nurse programme in your hospital and learn how to obtain resources and support from your hospital management...
TAVI pathways
21 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, look at logistics and outcomes of TAVI during the COVID-19 pandemic, be presented with a simple risk-stratification tool based on a pre-procedural multimarker approach in TAVI, study duration of hospitalisation in patients with complicated transcatheter aortic valve implantation, and...
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
